SCHEMBL14403761

SCHEMBL14403761

CC1(C)O[C@H]2[C@H]3C[C@@](OC(=O)CC=P(c4ccccc4)(c4ccccc4)c4ccccc4)(C[C@H]2O1)C(=O)O3

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 3/20 0.31
▸ OPRD1 P41143 3/20 0.31
▸ OPRK1 P41145 3/20 0.31
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12432564 1.00 OPRM1 (0.31) OPRM1OPRD1OPRK1ALDH1A1
SCHEMBL10099994 0.80 MGAM (0.31) —
SCHEMBL13825725 0.76 MGAM (0.33) —
SCHEMBL12511006 0.76 MGAM (0.33) —
SCHEMBL12510958 0.76 MGAM (0.33) —
SCHEMBL10099996 0.76 MGAM (0.33) —
SCHEMBL13825710 0.76 MGAM (0.33) —
SCHEMBL10063783 0.73 MGAM (0.35) —
SCHEMBL17466776 0.71 MGAM (0.34) —
SCHEMBL25468150 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9303050-B2 Intermediates for the preparation of analogs of Halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2016-04-05 — — US disclosed
EP-2949652-A1 Intermediates for the preparation of halichondrin B Eisai R&D Management Co., Ltd. (JP) 2015-12-02 — — EP disclosed
US-20150232490-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-08-20 — — US disclosed
EP-2522663-B1 Intermediates for the preparation of halichondrin B EISAI R&D MAN CO LTD (JP) 2015-04-01 — — EP disclosed
US-8975422-B2 Intermediates for the preparation of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-03-10 — — US disclosed
US-8884031-B2 Intermediates for the preparation of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2014-11-11 — — US disclosed
US-20140221635-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2014-08-07 — — US disclosed
US-20140163242-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2014-06-12 — — US disclosed
US-20130237711-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-09-12 — — US disclosed
US-8445701-B2 Intermediates for the preparation of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-05-21 — — US disclosed
US-20070244187-A1 Intermediates for the Preparation of Halichondrin B EISAI CO., LTD (JP) 2007-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244187-A1 Intermediates for the Preparation of Halichondrin B CDK4, CCNB1, CDK14 OPRM1 4834/4885OPRD1 4683/4885OPRK1 4642/4885
US-20130237711-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B DHPS, BMP2, CDK11B OPRM1 4483/4885OPRD1 4074/4885OPRK1 4014/4885
US-20140221635-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B ACVR1B, ACVR2B, BMP2 OPRM1 4354/4885OPRD1 3772/4885OPRK1 3742/4885
US-20150232490-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B DHPS, BMP2, CDK11B OPRM1 4483/4885OPRD1 4074/4885OPRK1 4014/4885
US-20140163242-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B DHPS, BMP2, CDK11B OPRM1 4483/4885OPRD1 4074/4885OPRK1 4014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback